Online citations, reference lists, and bibliographies.
← Back to Search

Nanostructured Lipid Carriers (NLCs) Versus Solid Lipid Nanoparticles (SLNs) For Topical Delivery Of Meloxicam

R. Khalil, A. Abd-elbary, M. A. Kassem, M. Ghorab, M. Basha
Published 2014 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Abstract Objective: The aim of this study was to develop nanostructured lipid carriers (NLCs) as well as solid lipid nanoparticles (SLNs) and evaluate their potential in the topical delivery of meloxicam (MLX). Materials and methods: The effect of various compositional variations on their physicochemical properties was investigated. Furthermore, MLX-loaded lipid nanoparticles-based hydrogels were formulated and the gels were evaluated as vehicles for topical application. Results and discussion: The results showed that NLC and SLN dispersions had spherical shapes with an average size between 215 and 430 nm. High entrapment efficiency was obtained ranging from 61.94 to 90.38% with negatively charged zeta potential in the range of −19.1 to −25.7 mV. The release profiles of all formulations exhibited sustained release characteristics over 48 h and the release rates increased as the amount of liquid lipid in lipid core increased. Finally, Precirol NLC with 50% Miglyol® 812 and its corresponding SLN were incorporated in hydrogels. The gels showed adequate pH, non-Newtonian flow with shear-thinning behavior and controlled release profiles. The biological evaluation revealed that MLX-loaded NLC gel showed more pronounced effect compared to MLX-loaded SLN gel. Conclusion: It can be concluded that lipid nanoparticles represent promising particulate carriers for topical application.
This paper references
10.1016/J.IJPHARM.2007.05.060
Nanostructured lipid carrier (NLC) based gel of celecoxib.
M. Joshi (2008)
Solid lipid nanoparticles (SLN) : an alternative colloidal carrier system for controlled drug delivery
R. Mueller (1995)
10.1159/000049400
Anti-Inflammatory Efficacy of Topical Preparations with 10% Hamamelis Distillate in a UV Erythema Test
B. Hughes-Formella (2002)
10.1016/J.EJPB.2005.12.007
Stabilization of all-trans retinol by loading lipophilic antioxidants in solid lipid nanoparticles.
J. Jee (2006)
10.1208/pt070491
Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A
Pallavi V Pople (2008)
10.1016/j.ejpb.2008.05.008
Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
Jia-You Fang (2008)
10.1016/S0939-6411(01)00233-8
Semisolid SLN dispersions for topical application: influence of formulation and production parameters on viscoelastic properties.
A. Lippacher (2002)
10.1080/02652040010000361
Encapsulation of retinoids in solid lipid nanoparticles (SLN).
V. Jenning (2001)
10.1016/J.IJPHARM.2006.01.040
Preparation and characteristics of monostearin nanostructured lipid carriers.
F. Hu (2006)
10.1016/J.EJPB.2005.06.002
Using cyclodextrin complexation to enhance secondary photoprotection of topically applied ibuprofen.
D. Godwin (2006)
10.1016/j.ijpharm.2008.01.045
Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation.
C. Puglia (2008)
10.1016/j.ijpharm.2010.09.007
Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis.
Y. Agrawal (2010)
10.1016/S0168-3659(03)00013-0
Optimization of a thermally reversible W/O/W multiple emulsion for shear-induced drug release.
L. Olivieri (2003)
10.1016/S0168-3659(99)00223-0
Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties.
V. Jenning (2000)
10.1208/pt060224
Etoposide-loaded nanoparticles made from glyceride lipids: Formulation, characterization, in vitro drug release, and stability evaluation
L. Harivardhan Reddy (2008)
10.1016/S0169-409X(01)00105-3
Solid lipid nanoparticles: production, characterization and applications.
W. Mehnert (2001)
10.1080/02652040500435295
Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization
E. Souto (2006)
10.1016/J.IJPHARM.2007.01.033
Formulation optimization of meloxicam sodium gel using response surface methodology.
Jui-Sheng Chang (2007)
10.1016/J.JCONREL.2005.09.045
Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
S. Lombardi Borgia (2005)
10.1016/j.ijpharm.2009.01.014
Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery.
Qingzhi Lv (2009)
10.1016/S0378-5173(98)00092-1
Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN) dispersions
C. Freitas (1998)
10.1016/J.IJBIOMAC.2006.03.006
Preparation and characterization of solid lipid nanoparticles loaded traditional Chinese medicine.
Y. Li (2006)
10.1111/J.1745-4603.1976.TB01259.X
VISCOSITY MEASUREMENTS AND INTERPRETATION OF VISCOSITY DATA
B. B. Sheth (1976)
10.1016/J.IJPHARM.2007.03.022
Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)--effects of formulation parameters on physicochemical stability.
Veerawat Teeranachaideekul (2007)
10.1016/j.jconrel.2005.09.052
Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting.
Huabing Chen (2006)
10.1016/J.IJPHARM.2007.05.061
Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery.
Kumar A. Shah (2007)
Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery
E. B. Soutoa (2004)
10.1016/S0168-3659(99)00007-3
Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain.
S. Yang (1999)
10.1016/J.JCONREL.2004.04.001
Glucocorticoid entrapment into lipid carriers--characterisation by parelectric spectroscopy and influence on dermal uptake.
R. Sivaramakrishnan (2004)
Solid lipid nanoparticles (SLNÔ) based on binary mixtures of liquid and solid lipids: a 1H NMR study
V Jenning (2000)
10.1016/j.jconrel.2010.02.006
Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers.
R. Patlolla (2010)
10.1016/j.ijpharm.2009.09.008
Development of a binary lipid nanoparticles formulation of itraconazole for parenteral administration and controlled release.
Jin-Ki Kim (2010)
10.1016/j.ijpharm.2010.05.005
Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.
Chun-Yang Zhuang (2010)
10.1016/S0378-5173(00)00623-2
Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles.
A. Lippacher (2001)
10.1002/JPS.20335
Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studies.
M. Ricci (2005)
10.1016/J.EJPB.2007.06.015
Lipid nanoparticles for alkyl lysophospholipid edelfosine encapsulation: development and in vitro characterization.
A. Estella-Hermoso de Mendoza (2008)
10.1016/J.COLSURFB.2005.08.005
Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system.
F. Hu (2005)
10.1016/S0928-0987(97)86243-4
Solid lipid nanoparticles (SLN) for controlled drug delivery
R. Mueller (1996)
10.1016/S0168-3659(02)00320-6
A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.
L. Mu (2003)
10.1016/j.pain.2006.12.014
Characterisation of ultraviolet-B-induced inflammation as a model of hyperalgesia in the rat
T. Bishop (2007)
10.1016/J.EJPB.2007.01.015
Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10) - development, physicochemical characterization and in vitro release studies.
Veerawat Teeranachaideekul (2007)
10.1016/S0378-5173(00)00462-2
Solid lipid nanoparticles (SLN™) based on binary mixtures of liquid and solid lipids: a 1H-NMR study
V. Jenning (2000)
10.1016/j.ijpharm.2008.10.003
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.
J. Pardeike (2009)
10.1016/J.POWTEC.2009.09.004
Formulation optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology
X. Zhang (2010)
10.1016/j.ijpharm.2010.02.004
SLN for topical application in skin diseases--characterization of drug-carrier and carrier-target interactions.
S. Küchler (2010)
10.1016/S0378-5173(00)00378-1
Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids.
V. Jenning (2000)
10.1016/J.JCIS.2004.10.012
Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures.
M. Garcia-Fuentes (2005)
10.1016/S0939-6411(00)00087-4
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
10.1016/S0378-5173(02)00221-1
Release profile of lidocaine HCl from topical liposomal gel formulation.
M. Glavas-Dodov (2002)
10.1016/S0939-6411(97)00150-1
Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.
A. Zur Mühlen (1998)
10.1016/S0142-9612(02)00578-1
The production and characteristics of solid lipid nanoparticles (SLNs).
DongZhi Hou (2003)
10.1016/j.ejpb.2010.05.003
Non-destructive methods of characterization of risperidone solid lipid nanoparticles.
Z. Rahman (2010)
10.1016/J.JCONREL.2005.06.006
Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration.
K. Manjunath (2005)
10.1016/j.ijpharm.2006.11.004
Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics.
V. V. Kumar (2007)
10.1016/J.POWTEC.2010.02.035
Effect of lipid nanoparticles containing fatty alcohols having different chain length on the ex vivo skin permeability of Econazole nitrate
V. Sanna (2010)
10.1080/03639040601150294
The Effect of Mixed-Solvent and Terpenes on Percutaneous Absorption of Meloxicam Gel
Jui-Sheng Chang (2007)
10.1016/J.JCONREL.2004.01.005
Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles.
V. Venkateswarlu (2004)
10.1016/J.IJPHARM.2006.08.007
Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.
J. Liu (2007)
10.1208/pt0804083
Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles
K. Vivek (2008)
Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticles (SLN) dispersions
C Freitas (1998)
10.1163/156856208785540091
A hybrid thermo-sensitive chitosan gel for sustained release of Meloxicam
Ye Wang (2008)
10.1208/pt070364
Evaluation of alternative strategies to optimize ketorolac transdermal delivery
C. Puglia (2008)
10.1016/J.IJPHARM.2005.08.011
Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.
F. Castelli (2005)
10.1016/j.ejpb.2009.12.008
Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.
C. Chen (2010)
10.1016/S0939-6411(99)00075-2
Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin.
V. Jenning (2000)
10.1016/0168-3659(94)90047-7
Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization
C. Schwarz (1994)
10.1016/J.IJPHARM.2006.12.043
Formulation and characterization of curcuminoids loaded solid lipid nanoparticles.
W. Tiyaboonchai (2007)



This paper is referenced by
10.21608/bfsa.2019.62265
DEVELOPMENT AND CHARACTERIZATION OF NANOSTRUCTURED LIPID CARRIERS FOR TRANSDERMAL DELIVERY OF MELOXICAM
Radwa Radwan (2019)
10.1080/03639045.2017.1386204
Topical phenytoin nanostructured lipid carriers: design and development
Amira Motawea (2018)
10.1016/BS.ABL.2016.04.001
How Lipid Cores Affect Lipid Nanoparticles as Drug and Gene Delivery Systems
A. Radaic (2016)
10.1016/j.ejpb.2018.10.017
Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release
Aldemar Gordillo‐Galeano (2018)
10.9734/BJPR/2014/7055
Formulation and Characterization of Nystatinloaded Nanostructured Lipid Carriers for Topical Delivery against Cutaneous Candidiasis.
R. Khalil (2014)
10.5530/IJPI.2019.2.10
Investigative Study on Impact of Solid: Liquid Lipid Ratio and Stabilizer Amount on Some Characteristics of Nanostructure Lipid Carriers of Quetiapine Fumarate
Shweta Agarwal (2019)
10.3109/03639045.2014.972412
In vitro lipolysis tests on lipid nanoparticles: comparison between lipase/co-lipase and pancreatic extract
V. Jannin (2015)
10.1007/s40005-018-00418-8
Potential of nanoparticulate carriers for improved drug delivery via skin
Alam Zeb (2018)
10.4028/www.scientific.net/SSP.222.159
Potential of Nanomaterials as Movers and Packers for Drug Molecules
I. P. Kaur (2014)
10.1016/j.ijpharm.2016.11.002
Encapsulation of NSAIDs for inflammation management: Overview, progress, challenges and prospects.
W. Badri (2016)
10.1016/J.JFOODENG.2015.12.017
Transport and release in nano-carriers for food applications
N. Dan (2016)
10.2174/1573409915666190722122827
Quality by Design Approach for Development and Characterisation of 
Solid Lipid Nanoparticles of Quetiapine Fumarate
Shweta Agarwal (2019)
10.1002/APP.42241
Design and optimization of alginate-chitosan-pluronic nanoparticles as a novel meloxicam drug delivery system
Shohreh Fattahpour (2015)
10.1021/la5030197
Nanostructured lipid carriers: effect of solid phase fraction and distribution on the release of encapsulated materials.
N. Dan (2014)
10.1016/J.JDDST.2018.12.014
A promising nystatin nanocapsular hydrogel as an antifungal polymeric carrier for the treatment of topical candidiasis
Mona M AbouSamra (2019)
10.1016/j.colsurfb.2020.111046
Influence of formulation variables on miconazole nitrate-loaded lipid based nanocarrier for topical delivery.
P. M. Al-maghrabi (2020)
RECORDS OF PHARMACEUTICAL AND BIOMEDICAL SCIENCES Solid lipid nanoparticles: a prospective approach for topical drug delivery
Passant M. Al-Maghrabi (2020)
10.1016/j.colsurfb.2019.06.002
DoE-based development, physicochemical characterization, and pharmacological evaluation of a topical hydrogel containing betamethasone dipropionate microemulsion.
Nguyen-Thach Tung (2019)
10.22159/IJPPS.2019V11I7.33115
DESIGN, OPTIMIZATION AND IN VITRO EVALUATION OF ANTIFUNGAL ACTIVITY OF NANOSTRUCTURED LIPID CARRIERS OF TOLNAFTATE
Ahmed R Gardouh (2019)
Topical Gel of Vitamin A Solid Lipid Nanoparticles: A Hopeful Promise as a Dermal Delivery System
Mahshid Boskabadi (2020)
10.1080/10837450.2020.1759630
A promising approach to develop nanostructured lipid carriers from solid lipid nanoparticles: preparation, characterization, cytotoxicity and nucleic acid binding ability
Ezgi Oner (2020)
10.1016/J.LWT.2015.05.013
Effect of distribution of solid and liquid lipid domains on transport of free radicals in nanostructured lipid carriers
S. Davis (2015)
SOLID LIPID NANOPARTICLES AND NANOSTRUCTURED LIPID CARRIERS OF TOLNAFTATE: DESIGN, OPTIMIZATION AND IN-VITRO EVALUATION
Mona M. Abousamra (2015)
10.1080/19932820.2018.1500347
An approach to revolutionize cataract treatment by enhancing drug probing through intraocular cell line
L. Wang (2018)
Microwave-assisted production of solid lipid nanoparticles
R. Shah (2016)
10.1080/10717544.2017.1413444
Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study
Shaimaa El-Housiny (2018)
Lipid-Based Drug Delivery Systems For The Enhancement Of Topical Delivery Of Benzocaine
Shereen H. Noshi (2018)
10.1002/jcb.26617
Encapsulation challenges, the substantial issue in solid lipid nanoparticles characterization
Sara Daneshmand (2018)
10.2174/2210681208666180320122534
Nanocarriers for Topical Drug Delivery: Approaches and Advancements
Gautam Singhvi (2019)
10.1016/j.jcis.2017.07.090
Preparation of lipid nanoparticles with high loading capacity and exceptional gastrointestinal stability for potential oral delivery applications.
Taoran Wang (2017)
10.1517/17425247.2015.1021681
Advances in lipid-based drug delivery: enhancing efficiency for hydrophobic drugs
G. Wang (2015)
10.1016/J.JDDST.2018.10.003
Nanostructured lipid carriers containing Amphotericin B: Development, in vitro release assay, and storage stability
R. R. Santiago (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar